1-Tetralone

We are 1-Tetralone CAS:529-34-0 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:1-Tetralone
CAS.NO:529-34-0
Synonyms:1-Tetralone
α-Tetralone
1-TETRALONE pure
3,4-Dihydro-1(2H)-naphthalenone
3,4-Dihydronaphthalen-1(2H)-one
 
Physical and Chemical Properties:
Density 1.1±0.1 g/cm3
Boiling Point 255.8±10.0 °C at 760 mmHg
Melting Point 2-7 °C(lit.)
Molecular Formula C10H10O
Molecular Weight 146.186
Flash Point 104.6±14.0 °C
 
Specification:
Appearance:Colorless to light yellow liquid
Assay:≥98.0%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Sertraline hydrochloride(CAS:79559-97-0).

1-Tetralone


Related News: Profitability continued to improve. The company’s comprehensive gross profit margin for the first three quarters was 36.06%, a year-on-year increase of 3.44 percentage points. Since this year, the company’s profitability has remained at a relatively high level. On the one hand, due to the decline in the trading business with lower profitability, the proportion has declined.ethyl 2-amino-5-oxo-7-propan-2-ylchromeno[2,3-b]pyridine-3-carboxylate CAS:68301-99-5 CMO services mainly involve four stages: pre-clinical research, clinical trials, sales of patented drugs after listing, and sales of original drug products after patents expire. Its advantages are: lower cost, guaranteed quality, good capacity flexibility, and favorable process Promotion.2,6-Difluorobenzaldehyde CAS:437-81-0 Most foreign drugmakers offered Beijing the lowest prices globally in a recent round of negotiations in order to get some of their new products included in national insurance program, a move that will help them gain access to more patients in less-affluent cities, officials said on Thursday.3'-Amino-2'-hydroxyacetophenone hydrochloride CAS:90005-55-3 Most foreign drugmakers offered Beijing the lowest prices globally in a recent round of negotiations in order to get some of their new products included in national insurance program, a move that will help them gain access to more patients in less-affluent cities, officials said on Thursday.Onconova Therapeutics, Inc. is a Phase 3-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer, with an initial focus on Myelodysplastic Syndromes (MDS).

Related Products
Product Name
DL-Norleucine View Details
3-Amino-2-chlorobenzotrifluoride View Details
1-Iodo-3,5-bis(trifluoromethyl)benzene View Details
3-(1-Piperazinyl)-1,2-Benzisothiazole manufacturer N-(3-trimethoxysilylpropyl)butan-1-amine manufacturer triethoxy-(2,3,4,5,6-pentafluorophenyl)silane Cas:20083-34-5 manufacturer Oxirane manufacturer 2-Ethylhexyl Salicylate manufacturer